.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Dow
Julphar
Federal Trade Commission
Express Scripts
McKinsey
Fuji
UBS
Argus Health
Mallinckrodt

Generated: September 22, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Which drugs does patent 7,838,564 protect, and when does it expire?


Patent ► Subscribe protects VALCHLOR and is included in one NDA.

This patent has twenty patent family members in fifteen countries.

Summary for Patent: ► Subscribe

Title:Stabilized compositions of volatile alkylating agents and methods of using thereof
Abstract: A composition and method for treatment of cancer. The composition for treating a skin disorder, comprising: a Nitrogen Mustard or an HX salt of the Nitrogen Mustard, wherein the Nitrogen Mustard or the HX salt of the Nitrogen Mustard is in a non-aqueous vehicle or carrier that does not include petrolatum or ethanol, wherein the non-aqueous vehicle or carrier that does not include petrolatum or ethanol does not include petrolatum or ethanol. The method comprises topically applying the composition of a Nitrogen Mustard or a HX salt of the Nitrogen Mustard to the affected skin, wherein the Nitrogen Mustard or the HX salt of the Nitrogen Mustard is in a non-aqueous vehicle or carrier that does not include petrolatum or ethanol, wherein the non-aqueous vehicle or carrier does not include petrolatum or ethanol.
Inventor(s): Alonso; Robert (Rye, NH), Crooks; Peter A. (Nicolasville, KY), Pimley; Mark A. (Westchester, PA), Al-Ghananeem; Abeer M. (Lexington, KY)
Assignee: Yaupon Therapeutics Inc. (Radnor, PA)
Application Number:12/549,258
Patent Claim Types:
see list of patent claims
Composition; Compound;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Actelion Pharms Ltd
VALCHLOR
mechlorethamine hydrochloride
GEL;TOPICAL202317-001Aug 23, 2013RXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: ► Subscribe

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
2,010,029,783► Subscribe
8,501,818Stabilized compositions of alkylating agents and methods of using same► Subscribe
8,501,817Stabilized compositions of alkylating agents and methods of using same► Subscribe
8,450,375Stabilized compositions of volatile alkylating agents and methods of using thereof► Subscribe
9,382,191Stabilized compositions of volatile alkylating agents and methods of using thereof► Subscribe
7,872,050Stabilized compositions of volatile alkylating agents and methods of using thereof► Subscribe
8,664,278Stabilized compositions of volatile alkylating agents and methods of using thereof► Subscribe
8,501,819Stabilized compositions of volatile alkylating agents and methods of using thereof► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: ► Subscribe

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia2006223076► Subscribe
Canada2600468► Subscribe
China101175735► Subscribe
China102036557► Subscribe
Cyprus1113305► Subscribe
Denmark1858864► Subscribe
European Patent Office1858864► SubscribePA2017026Lithuania► Subscribe
European Patent Office1858864► SubscribeCR 2017 00033Denmark► Subscribe
European Patent Office1858864► Subscribe300888Netherlands► Subscribe
European Patent Office2273876► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
US Army
Boehringer Ingelheim
Cerilliant
Citi
Baxter
Healthtrust
AstraZeneca
US Department of Justice
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot